{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:49:51Z","timestamp":1792432191841,"version":"4.5.0"},"reference-count":47,"publisher":"American Chemical Society (ACS)","issue":"9","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_ccbyncnd_termsofuse.html"}],"funder":[{"DOI":"10.13039\/100011272","name":"FP7 Health","doi-asserted-by":"publisher","award":["602666"],"award-info":[{"award-number":["602666"]}],"id":[{"id":"10.13039\/100011272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004522","name":"Top Institute Pharma","doi-asserted-by":"publisher","award":["T4-302"],"award-info":[{"award-number":["T4-302"]}],"id":[{"id":"10.13039\/501100004522","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Several trypanosomatid cyclic nucleotide phosphodiesterases (PDEs) possess a unique, parasite-specific cavity near the ligand-binding region that is referred to as the P-pocket. One of these enzymes, Trypanosoma brucei PDE B1 (TbrPDEB1), is considered a drug target for the treatment of African sleeping sickness. Here, we elucidate the molecular determinants of inhibitor binding and reveal that the P-pocket is amenable to directed design. By iterative cycles of design, synthesis, and pharmacological evaluation and by elucidating the structures of inhibitor-bound TbrPDEB1, hPDE4B, and hPDE4D complexes, we have developed 4a,5,8,8a-tetrahydrophthalazinones as the first selective TbrPDEB1 inhibitor series. Two of these, 8 (NPD-008) and 9 (NPD-039), were potent (Ki = 100 nM) TbrPDEB1 inhibitors with antitrypanosomal effects (IC50 = 5.5 and 6.7 \u03bcM, respectively). Treatment of parasites with 8 caused an increase in intracellular cyclic adenosine monophosphate (cAMP) levels and severe disruption of T. brucei cellular organization, chemically validating trypanosomal PDEs as therapeutic targets in trypanosomiasis.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.7b01670","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T19:08:54Z","timestamp":1524164934000},"page":"3870-3888","source":"Crossref","is-referenced-by-count":42,"title":["Targeting a Subpocket\nin\n                    <i>Trypanosoma brucei<\/i>\n                    Phosphodiesterase B1 (TbrPDEB1)\nEnables the Structure-Based Discovery\nof Selective Inhibitors with Trypanocidal Activity"],"prefix":"10.1021","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2329-0760","authenticated-orcid":true,"given":"Antoni R.","family":"Blaazer","sequence":"first","affiliation":[{"name":"Vrije Universiteit Amsterdam , , ,","place":["Amsterdam, The Netherlands, 1081 HZ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhimanyu K.","family":"Singh","sequence":"additional","affiliation":[{"name":"University of Kent , , ,","place":["Canterbury, U.K., CT2 7NJ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"de Heuvel","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Amsterdam , , ,","place":["Amsterdam, The Netherlands, 1081 HZ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewald","family":"Edink","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Amsterdam , , ,","place":["Amsterdam, The Netherlands, 1081 HZ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina M.","family":"Orrling","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Amsterdam , , ,","place":["Amsterdam, The Netherlands, 1081 HZ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan J. N.","family":"Veerman","sequence":"additional","affiliation":[{"name":"Mercachem , ,","place":["Nijmegen, The Netherlands, 6546 BB"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toine","family":"van den Bergh","sequence":"additional","affiliation":[{"name":"Mercachem , ,","place":["Nijmegen, The Netherlands, 6546 BB"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chimed","family":"Jansen","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Amsterdam , , ,","place":["Amsterdam, The Netherlands, 1081 HZ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Balasubramaniam","sequence":"additional","affiliation":[{"name":"University of Kent , , ,","place":["Canterbury, U.K., CT2 7NJ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter J.","family":"Mooij","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Amsterdam , , ,","place":["Amsterdam, The Netherlands, 1081 HZ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Custers","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Amsterdam , , ,","place":["Amsterdam, The Netherlands, 1081 HZ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Sijm","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Amsterdam , , ,","place":["Amsterdam, The Netherlands, 1081 HZ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel N. A.","family":"Tagoe","sequence":"additional","affiliation":[{"name":"University of Glasgow , , ,","place":["Glasgow, U.K., G12 8TA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titilola D.","family":"Kalejaiye","sequence":"additional","affiliation":[{"name":"University of Glasgow , , ,","place":["Glasgow, U.K., G12 8TA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane C.","family":"Munday","sequence":"additional","affiliation":[{"name":"University of Glasgow , , ,","place":["Glasgow, U.K., G12 8TA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Tenor","sequence":"additional","affiliation":[{"name":"Topadur Pharma AG , ,","place":["Schlieren, Switzerland, 8952"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Matheeussen","sequence":"additional","affiliation":[{"name":"University of Antwerp , , ,","place":["Wilrijk, Belgium, 2610"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8955-8016","authenticated-orcid":true,"given":"Maikel","family":"Wijtmans","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Amsterdam , , ,","place":["Amsterdam, The Netherlands, 1081 HZ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Siderius","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Amsterdam , , ,","place":["Amsterdam, The Netherlands, 1081 HZ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1226-2150","authenticated-orcid":true,"given":"Chris","family":"de Graaf","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Amsterdam , , ,","place":["Amsterdam, The Netherlands, 1081 HZ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Maes","sequence":"additional","affiliation":[{"name":"University of Antwerp , , ,","place":["Wilrijk, Belgium, 2610"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry P.","family":"de Koning","sequence":"additional","affiliation":[{"name":"University of Glasgow , , ,","place":["Glasgow, U.K., G12 8TA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Bailey","sequence":"additional","affiliation":[{"name":"IOTA Pharmaceuticals , ,","place":["Cambridge, U.K., CB4 0WS"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert Jan","family":"Sterk","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Amsterdam , , ,","place":["Amsterdam, The Netherlands, 1081 HZ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwan J. P.","family":"de Esch","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Amsterdam , , ,","place":["Amsterdam, The Netherlands, 1081 HZ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Brown","sequence":"additional","affiliation":[{"name":"University of Kent , , ,","place":["Canterbury, U.K., CT2 7NJ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1354-2848","authenticated-orcid":true,"given":"Rob","family":"Leurs","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Amsterdam , , ,","place":["Amsterdam, The Netherlands, 1081 HZ"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2018,4,19]]},"reference":[{"key":"2026090314014297500_cit1","first-page":"1","article-title":"Research\npriorities for Chagas disease, human African trypanosomiasis and leishmaniasis","volume":"975","author":"World Health Organization.","year":"2012","journal-title":"WHO Technical Report Series"},{"key":"2026090314014297500_cit2","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1126\/science.aaa3683","article-title":"Overcoming\nneglect of kinetoplastid diseases","volume":"348","author":"Bilbe","year":"2015","journal-title":"Science"},{"key":"2026090314014297500_cit3","first-page":"487","article-title":"Therapeutic\npotential of phosphodiesterase\ninhibitors in parasitic diseases","volume-title":"Handbook\nof Experimental Pharmacology","author":"Shakur","year":"2011"},{"key":"2026090314014297500_cit4","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.4155\/fmc.11.77","article-title":"Phosphodiesterase inhibitors\nas a\nnew generation of antiprotozoan drugs: exploiting the benefit of enzymes\nthat are highly conserved between host and parasite","volume":"3","author":"Seebeck","year":"2011","journal-title":"Future Med. Chem."},{"key":"2026090314014297500_cit5","doi-asserted-by":"publisher","first-page":"11559","DOI":"10.1074\/jbc.M005419200","article-title":"Characterization of\nTbPDE2A, a novel cyclic nucleotide-specific phosphodiesterase from\nthe protozoan parasite Trypanosoma brucei","volume":"276","author":"Zoraghi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2026090314014297500_cit6","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1073\/pnas.062716599","article-title":"The cAMP-specific phosphodiesterase TbPDE2C is an essential\nenzyme in bloodstream form Trypanosoma brucei","volume":"99","author":"Zoraghi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026090314014297500_cit7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.molbiopara.2005.09.018","article-title":"Cyclic nucleotide specific phosphodiesterases\nof the kinetoplastida: a unified nomenclature","volume":"145","author":"Kunz","year":"2006","journal-title":"Mol. Biochem. Parasitol."},{"key":"2026090314014297500_cit8","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1096\/fj.06-6818com","article-title":"The Trypanosoma brucei cAMP phosphodiesterases\nTbrPDEB1 and TbrPDEB2: flagellar enzymes that are essential for parasite\nvirulence","volume":"21","author":"Oberholzer","year":"2007","journal-title":"FASEB J."},{"key":"2026090314014297500_cit9","doi-asserted-by":"publisher","first-page":"8188","DOI":"10.1021\/jm201148s","article-title":"Pharmacological\nvalidation of Trypanosoma brucei phosphodiesterases\nB1 and B2 as druggable targets for African sleeping sickness","volume":"54","author":"Bland","year":"2011","journal-title":"J. Med. Chem."},{"key":"2026090314014297500_cit10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/infdis\/jir857","article-title":"Pharmacological validation\nof Trypanosoma brucei phosphodiesterases as novel\ndrug targets","volume":"206","author":"de Koning","year":"2012","journal-title":"J. Infect. Dis."},{"key":"2026090314014297500_cit11","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.bmc.2016.02.032","article-title":"Synthesis\nand evaluation of analogs of the phenylpyridazinone\nNPD-001 as potent trypanosomal TbrPDEB1 phosphodiesterase inhibitors\nand in vitro trypanocidals","volume":"24","author":"Veerman","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"2026090314014297500_cit12","doi-asserted-by":"publisher","first-page":"8745","DOI":"10.1021\/jm301059b","article-title":"Catechol pyrazolinones\nas trypanocidals:\nfragment-based design, synthesis, and pharmacological evaluation of\nnanomolar inhibitors of trypanosomal phosphodiesterase B1","volume":"55","author":"Orrling","year":"2012","journal-title":"J. Med. Chem."},{"key":"2026090314014297500_cit13","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/S1359-6446(05)03622-6","article-title":"Keynote review: phosphodiesterase-4\nas a therapeutic target","volume":"10","author":"Houslay","year":"2005","journal-title":"Drug Discovery Today"},{"key":"2026090314014297500_cit14","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1021\/jm040217u","article-title":"The next\ngeneration of phosphodiesterase\ninhibitors: structural clues to ligand and substrate selectivity of\nphosphodiesterases","volume":"48","author":"Manallack","year":"2005","journal-title":"J. Med. Chem."},{"key":"2026090314014297500_cit15","first-page":"85","article-title":"Pharmacology, clinical efficacy, and\ntolerability\nof phosphodiesterase-4 inhibitors: impact of human pharmacokinetics","volume-title":"Handbook of Experimental Pharmacology","author":"Tenor","year":"2011"},{"key":"2026090314014297500_cit16","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrd4228","article-title":"Advances\nin targeting cyclic nucleotide phosphodiesterases","volume":"13","author":"Maurice","year":"2014","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026090314014297500_cit17","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1021\/jm3017877","article-title":"Discovery\nof novel Trypanosoma brucei phosphodiesterase B1 inhibitors by virtual screening\nagainst the unliganded TbrPDEB1 crystal structure","volume":"56","author":"Jansen","year":"2013","journal-title":"J. Med. Chem."},{"key":"2026090314014297500_cit18","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/j.1365-2958.2007.05976.x","article-title":"Crystal structure\nof the Leishmania major phosphodiesterase LmjPDEB1\nand insight into the design of the parasite-selective inhibitors","volume":"66","author":"Wang","year":"2007","journal-title":"Mol. Microbiol."},{"key":"2026090314014297500_cit19","doi-asserted-by":"publisher","first-page":"11788","DOI":"10.1074\/jbc.M111.326777","article-title":"Biological and structural\ncharacterization of Trypanosoma cruzi phosphodiesterase\nC and Implications for design of parasite selective inhibitors","volume":"287","author":"Wang","year":"2012","journal-title":"J. Biol. Chem."},{"key":"2026090314014297500_cit20","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s10822-011-9458-5","article-title":"Active site similarity between human\nand Plasmodium falciparum phosphodiesterases: considerations\nfor antimalarial drug design","volume":"25","author":"Howard","year":"2011","journal-title":"J. Comput.-Aided\nMol. Des."},{"key":"2026090314014297500_cit21","doi-asserted-by":"publisher","first-page":"7029","DOI":"10.1021\/acs.jmedchem.5b01813","article-title":"PDEStrIAn: a phosphodiesterase structure and ligand\ninteraction annotated database as a tool for structure-based drug\ndesign","volume":"59","author":"Jansen","year":"2016","journal-title":"J. Med. Chem."},{"key":"2026090314014297500_cit22","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.1128\/AAC.00508-13","article-title":"Cyclic\nAMP effectors in African trypanosomes revealed\nby genome-scale RNA interference library screening for resistance\nto the phosphodiesterase inhibitor CpdA","volume":"57","author":"Gould","year":"2013","journal-title":"Antimicrob.\nAgents Chemother."},{"key":"2026090314014297500_cit23","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nrd2144","article-title":"Innovative lead discovery strategies for tropical diseases","volume":"5","author":"Nwaka","year":"2006","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026090314014297500_cit24","unstructured":"Hatzelmann, A.; Marx, D.; Steinhilber, W.; Sterk, G. J.\n          (Altana Pharma\nAG). Novel Phthalazinones. International Patent WO 2002085906, 2002."},{"key":"2026090314014297500_cit25","unstructured":"Hatzelmann, A.; Boss, H.; Ha\u0308fner, D.; Beume, R.; Kley, H.-P.; Van der laan, I. J.; Timmerman, H.; Sterk, G. J.; Van der Mey, M.\n          (Byk Gulden Lomberg Chemische\nFabrik GmbH). Phthalazinone PDE III\/IV Inhibitors. WO 199947505, 1999."},{"key":"2026090314014297500_cit26","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1021\/jm010838c","article-title":"Novel selective PDE4 inhibitors. 2. Synthesis and structure-activity\nrelationships of 4-aryl-substituted cis-tetra- and cis-hexahydrophthalazinones","volume":"44","author":"van der Mey","year":"2001","journal-title":"J. Med.\nChem."},{"key":"2026090314014297500_cit27","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/minf.201100076","article-title":"KNIME workflow\nto assess PAINS filters\nin SMARTS format. Comparison of RDKit and Indigo cheminformatics libraries","volume":"30","author":"Saubern","year":"2011","journal-title":"Mol. Inf."},{"key":"2026090314014297500_cit28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nbt.1598","article-title":"Design\nof phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing\ncognition with improved safety","volume":"28","author":"Burgin","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"2026090314014297500_cit29","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1107\/S0907444913015308","article-title":"Decision\nmaking in xia2","volume":"69","author":"Winter","year":"2013","journal-title":"Acta Crystallogr., Sect. D:\nBiol. Crystallogr."},{"key":"2026090314014297500_cit30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1107\/S0907444911007773","article-title":"Data processing\nand\nanalysis with the autoPROC toolbox","volume":"67","author":"Vonrhein","year":"2011","journal-title":"Acta Crystallogr.,\nSect. D: Biol. Crystallogr."},{"key":"2026090314014297500_cit31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"XDS","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr., Sect.\nD: Biol. Crystallogr."},{"key":"2026090314014297500_cit32","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1107\/S0907444913000061","article-title":"How good are my data and what is\nthe resolution?","volume":"69","author":"Evans","year":"2013","journal-title":"Acta Crystallogr., Sect. D:\nBiol. Crystallogr."},{"key":"2026090314014297500_cit33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1107\/S0907444910048675","article-title":"iMOSFLM:\na new graphical interface for diffraction-image processing with MOSFLM","volume":"67","author":"Battye","year":"2011","journal-title":"Acta Crystallogr., Sect. D: Biol. Crystallogr."},{"key":"2026090314014297500_cit34","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1107\/S090744491003982X","article-title":"An introduction\nto data reduction: space-group determination, scaling and intensity\nstatistics","volume":"67","author":"Evans","year":"2011","journal-title":"Acta Crystallogr., Sect. D: Biol.\nCrystallogr."},{"key":"2026090314014297500_cit35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview\nof the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr., Sect. D: Biol. Crystallogr."},{"key":"2026090314014297500_cit36","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser\ncrystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Crystallogr."},{"key":"2026090314014297500_cit37","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development\nof Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr., Sect. D: Biol. Crystallogr."},{"key":"2026090314014297500_cit38","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1107\/S0907444911001314","article-title":"REFMAC5\nfor the refinement of macromolecular crystal structures","volume":"67","author":"Murshudov","year":"2011","journal-title":"Acta Crystallogr., Sect. D: Biol. Crystallogr."},{"key":"2026090314014297500_cit39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular\ncrystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr., Sect. D:\nBiol. Crystallogr."},{"key":"2026090314014297500_cit40","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/bioinformatics\/btt055","article-title":"GROMACS 4.5:\na high-throughput\nand highly parallel open source molecular simulation toolkit","volume":"29","author":"Pronk","year":"2013","journal-title":"Bioinformatics"},{"key":"2026090314014297500_cit41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance\nmolecular simulations through multi-level parallelism from laptops\nto supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"2026090314014297500_cit42","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1002\/prot.22711","article-title":"Improved\nside-chain\ntorsion potentials for the Amber ff99SB protein force field","volume":"78","author":"Lindorff-Larsen","year":"2010","journal-title":"Proteins: Struct., Funct., Genet."},{"key":"2026090314014297500_cit43","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison\nof simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"2026090314014297500_cit44","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/1756-0500-5-367","article-title":"ACPYPE - AnteChamber PYthon Parser\ninterfacE","volume":"5","author":"Sousa da Silva","year":"2012","journal-title":"BMC Res. Notes"},{"key":"2026090314014297500_cit45","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1021\/ct700200b","article-title":"P-LINCS: a\nparallel linear constraint solver for molecular simulation","volume":"4","author":"Hess","year":"2008","journal-title":"J. Chem. Theory Comput."},{"key":"2026090314014297500_cit46","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1124\/mol.114.096016","article-title":"Potent trypanocidal curcumin analogs bearing a monoenone\nlinker motif act on Trypanosoma brucei by forming\nan adduct with trypanothione","volume":"87","author":"Alkhaldi","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"2026090314014297500_cit47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijpddr.2015.12.002","article-title":"Trypanocidal\naction of bisphosphonium\nsalts through a mitochondrial target in bloodstream form Trypanosoma brucei","volume":"6","author":"Alkhaldi","year":"2016","journal-title":"Int. J. Parasitol.: Drugs Drug\nResist."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.7b01670","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/61\/9\/3870\/67315572\/acs.jmedchem.7b01670.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/61\/9\/3870\/67315572\/acs.jmedchem.7b01670.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T08:11:35Z","timestamp":1788855095000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/61\/9\/3870\/764821\/Targeting-a-Subpocket-in-Trypanosoma-brucei"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,19]]},"references-count":47,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,4,19]]},"published-print":{"date-parts":[[2018,5,10]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.7b01670","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,19]]}}}